Characterization of Isoenzyme-Selective Inhibitors of Human Sphingosine Kinases

Peng Gao(Medical University of South Carolina), Charles D. Smith(Apogee Biotechnology (United States))
PLoS ONE
September 10, 2012
10.1371/journal.pone.0044543
Cited by 107

Related Papers

Pharmacology and Antitumor Activity of ABC294640, a Selective Inhibitor of Sphingosine Kinase-2
|Journal of Pharmacology and Experimental Therapeutics|2010|313
Single-cell multiomics reveals increased plasticity, resistant populations, and stem-cell–like blasts in <i>KMT2A</i>-rearranged leukemia
|Blood|2021|113
A Novel Sphingosine Kinase Inhibitor Induces Autophagy in Tumor Cells
|Journal of Pharmacology and Experimental Therapeutics|2010|111
Recent Progress in the Development of Opaganib for the Treatment of Covid-19
|Drug Design Development and Therapy|2022|27
Opaganib (ABC294640) Induces Immunogenic Tumor Cell Death and Enhances Checkpoint Antibody Therapy
|International Journal of Molecular Sciences|2023|18